Your browser doesn't support javascript.
loading
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Bar, Merav; Ott, Susan M; Lewiecki, E Michael; Sarafoglou, Kyriakie; Wu, Joy Y; Thompson, Matthew J; Vaux, Jonathan J; Dean, David R; Saag, Kenneth G; Hashmi, Shahrukh K; Inamoto, Yoshihiro; Dholaria, Bhagirathbhai R; Kharfan-Dabaja, Mohamed A; Nagler, Arnon; Rodriguez, Cesar; Hamilton, Betty K; Shah, Nina; Flowers, Mary E D; Savani, Bipin N; Carpenter, Paul A.
Affiliation
  • Bar M; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: mbar@fredhutch.org.
  • Ott SM; Department of Medicine, University of Washington, Seattle, Washington.
  • Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico; Bone Health TeleECHO, UNM Health Sciences Center, Albuquerque, New Mexico.
  • Sarafoglou K; Department of Pediatrics, Divisions of Endocrinology and Genetics & Metabolism, University of Minnesota Medical School, Minneapolis, Minnesota; Department of Experimental & Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
  • Wu JY; Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Thompson MJ; Department of Orthopedics and Sports Medicine, University of Washington, Seattle, Washington.
  • Vaux JJ; Department of Orthopedics and Sports Medicine, University of Washington, Seattle, Washington.
  • Dean DR; Department of Oral Medicine, University of Washington School of Dentistry, Seattle, Washington.
  • Saag KG; Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama.
  • Hashmi SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Dholaria BR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Nagler A; Bone Marrow Transplantation Department, Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Rodriguez C; Department of Internal Medicine Hematology and Oncology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
  • Hamilton BK; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Shah N; Division of Hematology-Oncology, University of California, San Francisco, California.
  • Flowers MED; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
  • Savani BN; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Carpenter PA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
Biol Blood Marrow Transplant ; 26(10): 1784-1802, 2020 10.
Article in En | MEDLINE | ID: mdl-32653624

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Document type: Article Country of publication: United States